Zai Lab Ltd Q2 2024 Earnings EPS Loss of 0.08, Revenue Surges to 100. ...
ZLAB Stock | USD 28.85 0.72 2.56% |
About 59% of Zai Lab's investor base is looking to short. The analysis of the overall investor sentiment regarding Zai Lab suggests that many traders are alarmed. The current market sentiment, together with Zai Lab's historical and current headlines, can help investors time the market. In addition, many technical investors use Zai Lab stock news signals to limit their universe of possible portfolio assets.
Zai |
Revenue 100.1 million for Q2 2024, representing a 45 percent year-over-year growth, surpassing the analyst estimate of 75.24 million.Net Loss 80.3 million for Q2
Read at gurufocus.com
Zai Lab Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Zai Lab can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Zai Lab Fundamental Analysis
We analyze Zai Lab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zai Lab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zai Lab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
Zai Lab is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
Zai Lab Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zai Lab stock to make a market-neutral strategy. Peer analysis of Zai Lab could also be used in its relative valuation, which is a method of valuing Zai Lab by comparing valuation metrics with similar companies.
Peers
Zai Lab Related Equities
CCCC | C4 Therapeutics | 8.59 | ||||
CGEM | Cullinan Oncology | 2.75 | ||||
BPMC | Blueprint Medicines | 1.35 | ||||
KRYS | Krystal Biotech | 0.26 | ||||
ROIV | Roivant Sciences | 0.16 | ||||
ASND | Ascendis Pharma | 0.18 | ||||
AKRO | Akero Therapeutics | 0.22 | ||||
ALNY | Alnylam Pharmaceuticals | 0.26 | ||||
APLS | Apellis Pharmaceuticals | 0.62 | ||||
MDGL | Madrigal Pharmaceuticals | 0.98 | ||||
ERAS | Erasca | 2.05 | ||||
LEGN | Legend Biotech | 2.46 | ||||
PTCT | PTC Therapeutics | 2.73 |
Complementary Tools for Zai Stock analysis
When running Zai Lab's price analysis, check to measure Zai Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zai Lab is operating at the current time. Most of Zai Lab's value examination focuses on studying past and present price action to predict the probability of Zai Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zai Lab's price. Additionally, you may evaluate how the addition of Zai Lab to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
CEOs Directory Screen CEOs from public companies around the world | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |